Medtronic’s Micra pacemaker associated with few complications in real-world analysis

Medtronic's Micra leadless pacemaker

Medtronic's Micra leadless pacemaker. Image courtesy of Medtronic. 

Medtronic’s Micra Transcatheter Pacing System (TPS) demonstrated a major complication rate of 2.7 percent through one year, according to data from a post-approval registry that will be presented May 10 at the Heart Rhythm Society’s annual scientific sessions in Boston.

Bardy Diagnostics™ Announces Validation of AI-Enabled Automatic Screening Technology for Atrial Fibrillation

SEATTLE, May 9, 2018 — Bardy Diagnostics, Inc., ("BardyDx"), a leading provider of ambulatory cardiac monitoring technologies and custom data solutions, including the Carnation Ambulatory Monitor ("CAM™"), the world's only P-wave centric™ ambulatory cardiac patch monitor and arrhythmia detection device, presented a poster today titled "Artificial Intelligence for the Automatic Detection of Atrial Fibrillation" at the Heart Rhythm Society 39th Annual Scientific Sessions that described a validated artificial intelligence-enabled (AI) screening technology to detect atrial fibrillation (AF) events.